Table 1.
No | Age/Gender/Aboriginal/Year | Co-morbidities | Prior lesions | Systolic BP at presenttion (mmHg) | Creatinine (μmol/L) (NR 50–100) | Blood culture | emmST a | STSSb |
1 | 45/F/Y/2001 | Alcohol excess | Right knee abrasion | 85 | 810 | Neg | new emmST | Y |
2 | 50/F/Y/1994 | Rheumatoid arthritis | Nil | 100 | 352 | Pos | emm56 | N |
3 | 47/F/Y/2000 | Hemodialysis, Hypertension | Nil | 85 | 739 | Pos | emmST3757 | Y |
4 | 38/F/Y/2001 | Type 2 diabetes, Hemodialysis, Cryptococcal pneumonitis | Buttock ulcer | 60 | 408 | Pos | no sequence | Y |
5 | 61/M/N/2001 | Rheumatoid arthritis, Corticosteroid therapy, Splenectomy | Vasculitic leg ulcer | 70 | 249 | Pos | emm3.2 | Y |
6 | 60/M/N/2001 | Rheumatoid arthritis, Methotrexate therapy, Pulmonary fibrosis | Leg ulcer | 90 | 237 | Neg | emm70 | Y |
7 | 27/M/N/1996 | Alcohol excess | Nil | 70 | 172 | Neg | emm58 | Y |
8 | 34/F/Y/1996 | SLE, Anti-Phospholipid syndrome, Corticosteroids, Renal impairment | Left thigh skin sore | 100 | 329 | Pos | emm69 | N |
9 | 44/M/Y/2000 | Type 2 diabetes, Alcohol excess, Renal impairment | Wound from catfish barb | 90 | 271 | Neg | emm49.3 | Y |
10 | 27/F/N/1999 | Nil | Nil | 90 | 77 | Neg | emm104 | N |
11 | 32/F/N/1999 | Nil | Buttock excoriation post-cycling | 100 | 177 | Neg | emm1 | N |
12 | 59/F/N/1999 | Nil | Nil | 90 | 118 | Neg | emm22 | Y |
13 | 50/M/Y/1997 | Alcohol excess, Cirrhosis | Leg ulceration | 100 | 112 | Pos | emm4 | N |
14 | 61/M/N/2001 | Alcohol excess, Hypertension, Gout | Ulcerated gouty tophus | 90 | 659 | Pos | emm3 | Y |
No | WCC/Lymphc (×109/L) | Albumin (g/L) (NR 35–45) | Infection site | Time to surgery after presentation | Operation performed | Antibiotic therapy | Myo-necrosis | Died |
1 | 5.7/0.2 | 21 | Right leg | 4 days | Debridement, Fasciotomy | Meropenem, Clindamycin | Yes | Yes |
2 | 5.2/0.5 | 22 | Right arm | 6 days | Fasciotomy | Penicillin | Yes | Yes |
3 | 9.6/0.3 | 33 | Right breast/Chest wall | 5 days | Debridement | Penicillin | No | Yes |
4 | 9.3/0.4 | 34 | Left leg/Abdominal wall | 2 days | Debridement | Penicillin, Clindamycin | No | Yes |
5 | 36.7/0.7 | 23 | Left leg | 1 day | Above knee amputation | Meropenem, Tobramycin, Clindamycin | No | No |
6 | 23.7/0.5 | 29 | Right leg | 0 days | Below knee amputation | Cefazolin, Clindamycin | No | No |
7 | 5.2/0.1 | 25 | Right leg | 5 days | Debridement | Penicillin, Clindamycin | No | No |
8 | 7.0/0.3 | 33 | Left leg/Abdominal wall | 7 days | Debridement | Penicillin, Clindamycin | Yes | No |
9 | 22.8/0.8 | 11 | Right foot | 2 days | Above knee amputation | Flucloxacillin, Metronidazole, Gentamicin | Yes | No |
10 | 23.3/1.0 | 29 | Left shoulder/Chest wall | 6 days | Debridement | Meropenem, Clindamycin | No | No |
11 | 21.8/0.5 | 17 | Right leg/Buttock/Perineum | 2 days | Debridement | Penicillin, Clindamycin | No | No |
12 | 4.8/0.4 | 18 | Left leg/Abdominal wall | 2 days | Debridement | Penicillin, Clindamycin | No | No |
13 | 10.5/0.7 | 21 | Left leg | 5 days | Debridement | Penicillin, Clindamycin | No | No |
14 | 4.0/0.2 | 28 | Right leg | 4 days | Above knee amputation | Penicillin, Clindamycin | No | No |
a Emm sequence type (see methods for details)
b Streptococcal toxic shock syndrome (see methods for details)
c WCC-total blood white cell count (normal range <11.0 × 109/L) Lymph-blood lymphocyte count